vs

Side-by-side financial comparison of Aurora Mobile Ltd (JG) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

RECURSION PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($35.5M vs $25.0M, roughly 1.4× Aurora Mobile Ltd). Aurora Mobile Ltd runs the higher net margin — -1.4% vs -304.2%, a 302.8% gap on every dollar of revenue. Aurora Mobile Ltd produced more free cash flow last quarter ($772.0K vs $-47.3M).

Aurora Innovation, Inc., doing business as Aurora, is a self-driving vehicle technology company based in Pittsburgh, Pennsylvania. Aurora has developed the Aurora Driver, a computer system that can be integrated into cars for autonomous driving. It was co-founded by Chris Urmson, the former chief technology officer of Google/Alphabet Inc.'s self-driving team, which became known as Waymo, as well as by Sterling Anderson, former head of Tesla Autopilot, and Drew Bagnell, former head of Uber's a...

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

JG vs RXRX — Head-to-Head

Bigger by revenue
RXRX
RXRX
1.4× larger
RXRX
$35.5M
$25.0M
JG
Higher net margin
JG
JG
302.8% more per $
JG
-1.4%
-304.2%
RXRX
More free cash flow
JG
JG
$48.1M more FCF
JG
$772.0K
$-47.3M
RXRX

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
JG
JG
RXRX
RXRX
Revenue
$25.0M
$35.5M
Net Profit
$-360.0K
$-108.1M
Gross Margin
66.3%
59.8%
Operating Margin
-1.4%
-304.8%
Net Margin
-1.4%
-304.2%
Revenue YoY
681.7%
Net Profit YoY
39.6%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JG
JG
RXRX
RXRX
Q4 25
$35.5M
Q3 25
$5.2M
Q2 25
$25.0M
$19.2M
Q1 25
$14.7M
Q4 24
$43.3M
$4.5M
Q3 24
$26.1M
Q2 24
$14.4M
Q1 24
$13.8M
Net Profit
JG
JG
RXRX
RXRX
Q4 25
$-108.1M
Q3 25
$-162.3M
Q2 25
$-360.0K
$-171.9M
Q1 25
$-202.5M
Q4 24
$-965.0K
$-178.9M
Q3 24
$-95.8M
Q2 24
$-97.5M
Q1 24
$-91.4M
Gross Margin
JG
JG
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
66.3%
-4.9%
Q1 25
-48.0%
Q4 24
66.1%
-181.4%
Q3 24
53.7%
Q2 24
36.2%
Q1 24
19.1%
Operating Margin
JG
JG
RXRX
RXRX
Q4 25
-304.8%
Q3 25
-3327.6%
Q2 25
-1.4%
-916.8%
Q1 25
-1297.9%
Q4 24
-3.1%
-4042.4%
Q3 24
-377.1%
Q2 24
-697.4%
Q1 24
-698.4%
Net Margin
JG
JG
RXRX
RXRX
Q4 25
-304.2%
Q3 25
-3135.3%
Q2 25
-1.4%
-894.2%
Q1 25
-1373.3%
Q4 24
-2.2%
-3935.5%
Q3 24
-367.5%
Q2 24
-676.6%
Q1 24
-662.4%
EPS (diluted)
JG
JG
RXRX
RXRX
Q4 25
$-0.17
Q3 25
$-0.36
Q2 25
$-0.41
Q1 25
$-0.50
Q4 24
$-0.56
Q3 24
$-0.34
Q2 24
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JG
JG
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$16.7M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$9.0M
$1.1B
Total Assets
$53.2M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JG
JG
RXRX
RXRX
Q4 25
$743.3M
Q3 25
$659.8M
Q2 25
$16.7M
$525.1M
Q1 25
$500.5M
Q4 24
$16.3M
$594.4M
Q3 24
$427.6M
Q2 24
$474.3M
Q1 24
$296.3M
Total Debt
JG
JG
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
JG
JG
RXRX
RXRX
Q4 25
$1.1B
Q3 25
$1.0B
Q2 25
$9.0M
$919.1M
Q1 25
$933.9M
Q4 24
$9.3M
$1.0B
Q3 24
$524.6M
Q2 24
$584.4M
Q1 24
$401.2M
Total Assets
JG
JG
RXRX
RXRX
Q4 25
$1.5B
Q3 25
$1.4B
Q2 25
$53.2M
$1.3B
Q1 25
$1.3B
Q4 24
$51.8M
$1.4B
Q3 24
$726.5M
Q2 24
$775.9M
Q1 24
$557.8M
Debt / Equity
JG
JG
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JG
JG
RXRX
RXRX
Operating Cash FlowLast quarter
$795.0K
$-46.1M
Free Cash FlowOCF − Capex
$772.0K
$-47.3M
FCF MarginFCF / Revenue
3.1%
-133.1%
Capex IntensityCapex / Revenue
0.1%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JG
JG
RXRX
RXRX
Q4 25
$-46.1M
Q3 25
$-117.4M
Q2 25
$795.0K
$-76.4M
Q1 25
$-132.0M
Q4 24
$1.2M
$-115.4M
Q3 24
$-59.2M
Q2 24
$-82.2M
Q1 24
$-102.3M
Free Cash Flow
JG
JG
RXRX
RXRX
Q4 25
$-47.3M
Q3 25
$-117.6M
Q2 25
$772.0K
$-79.6M
Q1 25
$-133.8M
Q4 24
$553.0K
$-116.7M
Q3 24
$-63.8M
Q2 24
$-83.4M
Q1 24
$-109.0M
FCF Margin
JG
JG
RXRX
RXRX
Q4 25
-133.1%
Q3 25
-2272.5%
Q2 25
3.1%
-413.9%
Q1 25
-907.4%
Q4 24
1.3%
-2567.7%
Q3 24
-244.6%
Q2 24
-578.5%
Q1 24
-789.9%
Capex Intensity
JG
JG
RXRX
RXRX
Q4 25
3.5%
Q3 25
4.7%
Q2 25
0.1%
16.4%
Q1 25
12.4%
Q4 24
1.4%
28.6%
Q3 24
17.5%
Q2 24
8.2%
Q1 24
48.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons